MicrobeWorld App


Microbes After Hours

Click for "Microbes After Hours" videos

Agar Art Contest 2016


Featured Image

Featured Video


Join MicrobeWorld


ASM House 200X200

Subscribe via Email


Influenza: What's the point of making good, safe vaccines if people won't accept them?

That H1N1 pandemic....no, it didn't lead to bodies piled high in the streets. But the point is, it could have -- pandemics sometimes do. And were we prepared? No, we were not.

That's the bottom line of a perspective published in the New England Journal of Medicine right before Thanksgiving when our thoughts of birds had all to do with feasts and not the influenza A viruses many wild ones naturally harbor.

The commentary, which you can read in full on the Web, was penned by three scientists at RAND in Santa Monica and its main theme was vaccine acceptance. Certainly, they write, one of the problems with the H1N1 vaccine was how long it took to make it -- the virus emerged in the public consciousness in March 2009 but the vaccine wasn't ready for sizeable distribution until December 2009 -- speedy, as flu-vaccine ramp-ups go, but not speedy enough. "By that point, the pandemic had passed its peak, and public demand for vaccination was in swift decline. In the end, manufacturers were left with 70 million unused doses."

But there's another big point here, the scientists say: You can ramp up all you want on technology but unless you get people to get the vaccine it's not going to help too much.

Comments (0)

Collections (0)


American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use